Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF JANUARY 13, 2012 FBO #3702
SOLICITATION NOTICE

B -- Reagents

Notice Date
1/11/2012
 
Notice Type
Combined Synopsis/Solicitation
 
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Rockledge Dr. Bethesda, MD, Office of Acquisitions, 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, Maryland, 20892-7902
 
ZIP Code
20892-7902
 
Solicitation Number
NHGRI-CSB-(HG)-2012-051-RSF
 
Archive Date
2/4/2012
 
Point of Contact
Rashida S. Ferebee, Phone: 3014352605
 
E-Mail Address
ferebeers@nhlbi.nih.gov
(ferebeers@nhlbi.nih.gov)
 
Small Business Set-Aside
N/A
 
Description
The National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisition (OA) on behalf of the National Human Genome Research Institute (NHGRI), NIH Chemical Genomics Center (NCGC), intends to negotiate and award a purchase order on a noncompetitive sole source basis to Promega Corporation, 2800 Woods Hollow Road, Madison, Wisconsin, 53711 for the procurement of Qty, 20- BacTiter TM Glo Microbial Cell Assay, 10x100ml. The mission of the NCGC is to apply the tools of small molecule screening and discovery to the development of chemical probe research tools, for use in the study of protein and cell functions, and biological processes relevant to physiology and disease. NCGC will optimize biochemical, cellular and model organism-based assays submitted by the biomedical research community; perform automated high-throughput screening (HTS); and perform chemistry optimization on confirmed hits to produce chemical probes for dissemination to the research community. The sole source determination is based upon the fact that Promega Corporation does not distribute this item to any other resellers; as such, Promega Corporation is the sole provider of this particular reagent. The BacTiterGlo assay from Promega consists of a proprietary reagent. This reagent has been specifically optimized for these projects. This item is critical to the assay needed to determine cell viability. NCGC cannot use a different reagent without complete re-optimization. This request is a sole source procurement required in order to avoid the introduction of new variables into this ongoing project. NCGC must use the same variables in the assays to maintain integrity from the data and to achieve the desired outcomes. A switch to a different detection reagent would necessitate re-optimizing the assay with no guarantees that the results would be similar. This would entail unacceptable substantial time delays and enormous additional costs. Industry Classification (NAICS) Code is 325413, with business size standard 500 Employees. The acquisition is being conducted under FAR Part 13, simplified acquisition procedures, therefore the requirements of FAR Part 6 B Competitive Requirements are not applicable (FAR Part 6.001) and the resultant purchase order will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC)05-54 (November 2, 2011). This acquisition is set-aside for small business. Interested firms may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent to award is not a request for competitive proposals. However, all proposals received by the closing date, January 20,, 2012 will be considered by the Government. A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Inquires to this announcement, referencing synopsis number, NHGRI-CSB-(HG)-2012-051-RSF may be submitted to the National Heart, Lung and Blood Institute, Office of Acquisition, Procurement Branch, 6701 Rockledge Drive, Suite 6149, Bethesda, Maryland 20892-7902, Attention: Rashida Ferebee. Response may be submitted electronically to Rashida.ferebee@nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NHLBI/ NHGRI-CSB-(HG)-2012-051-RSF/listing.html)
 
Place of Performance
Address: NIH/NCGC, Building B, 9800 Medical Center Drive, Rockville, Maryland, 20850, United States
Zip Code: 20850
 
Record
SN02653147-W 20120113/120111235433-b6a012f07ad88f2c2829fa1f32eb7d65 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.